Showing results for oncology
Non-Small Cell Lung Cancer Treatments and Signs. Non-Small Cell Lung Cancer NSCLC is the most common form of lung cancer and its management depends on how far the disease has spread, the histology of the tumor, and the presence of specific molecular features. In recent years the landscape of treatment has become more personalized, with options ranging from surgery to systemic therapies that target particular mutations or harness the immune system.
Mesothelioma prognosis is a topic that patients and families often approach with a mix of urgency and caution. While no one can predict an exact outcome for a specific person, clinicians can outline the likely course of the disease based on several well est...
Mesothelioma is a rare cancer that most often develops in the lining around the lungs or abdomen. Because its signs can resemble more common illnesses, recognizing the indications early can help people seek timely medical evaluation. This article summarizes...
Squamous cell carcinoma that has remained untreated for an extended period presents a clinical challenge that goes beyond the visible lesion. This form of cancer arises from the flat, scale-like cells that line many surfaces of the body, including the skin ...
Prostate cancer therapy weaves together surgical science, radiation physics, pharmacology, and a close read of what the patient values. The disease is varied; some men have localized tumors that can be targeted aggressively with the aim of cure, while other...
TNBC treatment in the United States has evolved rapidly over the past decade, driven by advances in immunotherapy, targeted therapies, and antibody drug conjugates. Triple negative breast cancer, defined by the absence of estrogen and progesterone receptors...
Latest Treatment To Reverse Multiple Myeloma remains a topic of intense research and clinical hope. In recent years the field has shifted from solely managing symptoms to deploying highly targeted immunotherapies designed to harness the patient’s own immune...
Multiple myeloma is a complex cancer of plasma cells that sits at the crossroads of hematology and oncology. For many patients, the goal has shifted from simple disease control to achieving deeper, longer lasting remissions and, in some cases, meaningful reversal of disease burden.
Triple-negative breast cancer, or TNBC, is a form of breast cancer that tests negative for estrogen receptors, progesterone receptors, and the HER2 protein. This combination means that TNBC may not respond to some of the hormonal or targeted therapies used ...
Trodelvy, also known by its generic name sacituzumab govitecan, has established a distinctive role in the treatment landscape of breast cancer. It is most prominently used in metastatic breast cancer settings where previous lines of therapy have failed, off...
Mesothelioma is a rare and aggressive cancer that develops in the lining that covers internal organs most often the lungs.
Non small cell lung cancer NSCLC is the most common type of lung cancer and its course can be highly variable. In many people the disease does not cause obvious symptoms at first, which means that signs may be subtle or nonspecific.
ALK rearranged non small cell lung cancer is a distinct biological subgroup that influences how the disease starts, spreads, and responds to therapy.
